相关实验视频

Updated: Jan 18, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

在患有骨髓增殖新生体的患者中,骨髓增殖和降低强度的异质移植

Andrew D Trunk¹, Yanwen Chen², Aaron T Gerds¹

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Hematology/oncology and stem cell therapy

|September 12, 2025

概括

全基性造血细胞移植 (allo-HCT) 为髓纤维化 (MF) 和慢性骨髓单细胞白血病 (CMML) 提供治疗潜力. 对当代患者的结果分析表明,分子数据可以优化患者选择并减少复发,以改善存活率.

科学领域:

血液学血液学血液学
在瘤学瘤学.
干细胞移植干细胞移植

背景情况:

全基性造血细胞移植 (allo-HCT) 是对髓纤维化 (MF) 和慢性骨髓单细胞白血病 (CMML) 的潜在治疗方法.
由于年龄较大,并发病症和晚期疾病,患者选择和移植时间具有挑战性.
本研究调查了MF和CMML的当代alo-HCT结果,并结合了分子数据来改进治疗方法.

研究的目的:

在当代患者队列中分析所有基性造血细胞移植 (allo-HCT) 针对骨髓纤维化 (MF) 和慢性骨髓单细胞白血病 (CMML) 的结果.
评估分子和细胞遗传数据对alo-HCT结果的影响.
为这些血液性恶性瘤制定统一的移植策略提供信息.

主要方法:

在克利夫兰诊所接受alo-HCT的MF和CMML患者的回顾性分析 (2010年1月 - 2023年4月).
包括所有捐赠者类型和移植来源.
单独分析MF和CMML的结果,包括下一代测序 (NGS) 数据.

主要成果:

分析了59名多发性肌痛患者 (47.5%的中位数为41个月) 和33名CMML患者 (39.4%的中位数为46.8个月).
在MF中,JAK2 V617F突变很常见;分子数据 (JAK2+,额外的突变) 与更好的MF存活率相关.
在CMML中,ASXL1突变是常见的;细胞遗传异常与更糟糕的整体存活率有关,复发是死亡的重要原因,特别是在减少强度调节 (RIC) 后.

结论:

老年患者 (≥65) 和那些接受MF和CMML减强强度调节 (RIC) allo-HCT的患者的生存率下降.
结合分子和细胞遗传数据的策略对于优化患者选择至关重要.
进一步的研究应该集中在减少复发率和完善多发性纤维素和CMML的移植方法上.

关键词:

异构性造血细胞移植异构性造血细胞移植慢性骨髓单细胞白血病慢性骨髓单细胞白血病强度的强度的强度.骨髓纤维化骨髓纤维化骨髓扩散性瘤是什么

更多相关视频

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...